Related Experiment Video

Updated: Oct 10, 2025

The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers
12:22

The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers

Published on: January 22, 2013

33.8K

[Precision medicine and renal cell carcinoma: current situation and the future]

K Gong1, Q Tang1, J C Zhou1

  • 1Department of Urology, Peking University First Hospital, Institute of Urology, National Urological Cancer Center, Beijing 100034, China.

Zhonghua Yi Xue Za Zhi
|December 13, 2021
PubMed

Insights

Renal cell carcinoma (RCC) is rising, with new treatments like checkpoint inhibitors showing promise. Future research into biomarkers may improve prognosis prediction and personalize treatment for kidney cancer.

Area of Science:

  • Oncology
  • Nephrology
  • Biomarker Research

Background:

  • Increasing incidence of renal cell carcinoma (RCC) necessitates advanced understanding.
  • Current prognosis relies on clinical factor-based models.
  • Emerging therapies include tyrosine kinase inhibitors and checkpoint inhibitors.

Purpose of the Study:

  • To review the current understanding of renal cell carcinoma mechanisms and characteristics.
  • To highlight advancements in prognosis prediction and treatment strategies for RCC.
  • To explore the potential of novel biomarkers in guiding RCC management.

Main Methods:

  • Literature review of recent research on renal cell carcinoma.
  • Analysis of clinical factors and prognostic models.
  • Evaluation of the efficacy of new therapeutic agents and biomarkers.

Main Results:

  • Checkpoint inhibitors demonstrate significant success in RCC treatment.
  • Tyrosine kinase inhibitors remain a cornerstone of traditional therapy.
  • Biomarker discovery is crucial for future treatment personalization.

Conclusions:

  • Advances in understanding RCC biology are improving patient outcomes.
  • Personalized medicine approaches leveraging biomarkers are expected to enhance prognosis prediction and treatment selection for kidney cancer.

More Related Videos

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies06:38

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

Published on: April 12, 2017

13.8K
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

935

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
104
Renal Drug Clearance: Overview01:06

Renal Drug Clearance: Overview

Renal clearance is a crucial parameter in pharmacokinetics that quantifies the rate at which the kidneys excrete a drug. It represents a constant fraction of the central volume of distribution containing the drug that the kidney eliminates per unit of time.
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
387
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
74